ArticleInternational journal of clinical oncology2024

Prognostic significance of initial tumor shrinkage in patients with stage III non-small cell lung cancer treated with durvalumab following chemoradiotherapy.

Yuto Terashima et al.PubMed ↗Publisher ↗

No numbers read from the abstract.